Allergan (AGN): Set For a 30% Move - RBC
Tweet Send to a Friend
Allergan (NYSE: AGN)RBC Capital analyst, Randall Stanicky, reiterated his Outperform rating on shares of Allergen (NYSE: AGN) and cut his ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


